Innohep 8,000 IU in 0.4 ml, Solution for injection
Authorisation PA0046/060/012 · Leo Laboratories Limited
- Licence holder
- Leo Laboratories Limited (all products →)
- Active substance
- Tinzaparin sodium
- Clinical trials
- 7 clinical trials →
- Dosage form
- Solution for injection
- Route of administration
- Subcutaneous use
- ATC codes
- B01AB, B01AB10
- First authorised
- 07/11/2014
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Tinzaparin sodium: supply and approvals
20 authorised products on the HPRA list contain Tinzaparin sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 12 years (since 7 November 2014). The HPRA list marks it as marketed in Ireland.
Other medicines with Tinzaparin sodium in Ireland
19 other products on the HPRA list contain Tinzaparin sodium, from 3 licence holders; 10 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Innohep 10,000 IU in 0.5 ml, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 10,000 IU/ml solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 12,000 IU in 0.6 ml, Solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 14,000 IU in 0.7 ml, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 16,000 IU in 0.8 ml, Solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 18,000 IU in 0.9 ml, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 2,500 IU, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 20,000 IU/ml Solution for Injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 3,500 IU, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 4,500 IU, solution for injection | Leo Laboratories Limited | National authorisation (PA) | Marketed |
| Innohep 10,000 IU in 0.5 ml, solution for injection | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Innohep 14,000 IU in 0.7 ml, solution for injection | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
Other substances in ATC group B01AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 7 other active substances share the group B01AB with this product:
Enoxaparin sodium (17) · Heparin sodium (8) · Sodium chloride (2) · Disodium phosphate dodecahydrate (2) · Citric acid monohydrate (2) · Danaparoid sodium (1) · Bemiparin sodium (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Leo Laboratories Limited holds 18 products on the HPRA list, with 8 different active substances; 18 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.